New indication of tolvaptan as approved by FDA recently
Tolvaptan is a vasopressin antagonist used for SIADH Now approved for PCKD Ref : HH Sharma 3rd ed.
Phenylketonuria
Pancreatic tumours
Polycystic ovarian disease
Polycystic kidney disease
All India exam